ATP-13C (dilithium)
CAT:
804-HY-B2176S2
Size:
1 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

ATP-13C (dilithium)
- UNSPSC Description: ATP-13C (Adenosine 5'-triphosphate-13C) dilithium is 13C-labeled ATP (HY-B2176). ATP (Adenosine 5'-triphosphate) is a central component of energy storage and metabolism in vivo. ATP provides the metabolic energy to drive metabolic pumps and serves as a coenzyme in cells. ATP is an important endogenous signaling molecule in immunity and inflammation.
- Target Antigen: Endogenous Metabolite; Isotope-Labeled Compounds
- Type: Isotope-Labeled Compounds
- Related Pathways: Metabolic Enzyme/Protease;Others
- Applications: Metabolism-protein/nucleotide metabolism
- Field of Research: Metabolic Disease; Inflammation/Immunology
- Assay Protocol: https://www.medchemexpress.com/atp-13c-dilithium.html
- Solubility: 10 mM in DMSO
- Smiles: O[C@H]([C@H](O1)CO[P](O[P](O[P](O)(O[Li])=O)(O[Li])=O)(O)=O)[C@@H](O)[C@@H]1N2C3=NC=NC(N)=C3N=[13CH]2
- Molecular Weight: 520.04
- References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Swennen EL, et al. Immunoregulatory effects of adenosine 5'-triphosphate on cytokine release from stimulated whole blood. Eur J Immunol. 2005 Mar;35(3):852-8.|[3]M J L Bours, et al. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther. 2006 Nov;112(2):358-404.|[4]Shuo Xu, et al. Doxycycline inhibits NAcht Leucine-rich repeat Protein 3 inflammasome activation and interleukin-1β production induced by Porphyromonas gingivalis-lipopolysaccharide and adenosine triphosphate in human gingival fibroblasts. Arch Oral Biol. 2019 Nov;107:104514.|[5]Yang Xiang, et al. Adenosine-5'-Triphosphate (ATP) Protects Mice against Bacterial Infection by Activation of the NLRP3 Inflammasome. PLoS One. 2013; 8(5): e63759.
- Shipping Conditions: Room temperature
- Clinical Information: No Development Reported